Organoselenium Transition Metal Complexes As Promising Candidates in Medicine area

Overview

Journal J Biol Inorg Chem

Publisher Springer

Specialty Biochemistry

Date 2024 Aug 9

PMID 39123093

Authors

Marina Kostic

Jovana Marjanovic

Vera Divac

Affiliations

Soon will be listed here.

Abstract

The medicinal properties of transition metal complexes are greatly influenced by the nature and physico-chemical features of the ligand present in the complex structure. Due to the unique biological properties of the organoselenium compounds reflected in the variety of pharmacological activities (such as antioxidative, antiviral, antimicrobial and anticancer), the last years have brought increased interest for their use as a ligands compounds in the design and syntheses of range of transition metal-based coordination compounds that have been explored as antitumor and antimicrobial agents. Our aim in this review is to provide the overview of an recent development of the transition metal complexes bearing organoselenium ligands in the structure that could be promising choice for the treatment of various diseases, particularly cancer and infective diseases. For this purpose, the complexes of Co, Ni, Cu, Zn, Ru, Pd, Pt, Au and Sn as the most explored examples will be included and discussed.

References

Hou W, Xu H . Incorporating Selenium into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities. J Med Chem. 2022; 65(6):4436-4456. DOI: 10.1021/acs.jmedchem.1c01859. View

Bellinger F, Raman A, Reeves M, Berry M . Regulation and function of selenoproteins in human disease. Biochem J. 2009; 422(1):11-22. PMC: 2912286. DOI: 10.1042/BJ20090219. View

Brown K, Arthur J . Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001; 4(2B):593-9. DOI: 10.1079/phn2001143. View

Pieczynska J, Grajeta H . The role of selenium in human conception and pregnancy. J Trace Elem Med Biol. 2014; 29:31-8. DOI: 10.1016/j.jtemb.2014.07.003. View

Steinbrenner H, Speckmann B, Klotz L . Selenoproteins: Antioxidant selenoenzymes and beyond. Arch Biochem Biophys. 2016; 595:113-9. DOI: 10.1016/j.abb.2015.06.024. View

Barchielli G, Capperucci A, Tanini D . The Role of Selenium in Pathologies: An Updated Review. Antioxidants (Basel). 2022; 11(2). PMC: 8868242. DOI: 10.3390/antiox11020251. View

Zeppilli D, Madabeni A, Sancineto L, Bagnoli L, Santi C, Orian L . Role of Group 12 Metals in the Reduction of HO by Santi's Reagent: A Computational Mechanistic Investigation. Inorg Chem. 2023; 62(42):17288-17298. PMC: 10598800. DOI: 10.1021/acs.inorgchem.3c02568. View

Sonego J, de Diego S, Szajnman S, Gallo-Rodriguez C, Rodriguez J . Organoselenium Compounds: Chemistry and Applications in Organic Synthesis. Chemistry. 2023; 29(52):e202300030. DOI: 10.1002/chem.202300030. View

10.

Hou W, Dong H, Zhang X, Wang Y, Su L, Xu H . Selenium as an emerging versatile player in heterocycles and natural products modification. Drug Discov Today. 2022; 27(8):2268-2277. DOI: 10.1016/j.drudis.2022.03.020. View

11.

Boer J, Mulrooney S, Hausinger R . Nickel-dependent metalloenzymes. Arch Biochem Biophys. 2013; 544:142-52. PMC: 3946514. DOI: 10.1016/j.abb.2013.09.002. View

12.

McCall K, Huang C, Fierke C . Function and mechanism of zinc metalloenzymes. J Nutr. 2000; 130(5S Suppl):1437S-46S. DOI: 10.1093/jn/130.5.1437S. View

13.

Guengerich F . Introduction to Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes. J Biol Chem. 2018; 293(13):4603-4605. PMC: 5880126. DOI: 10.1074/jbc.TM118.002255. View

14.

Dimiza F, Papadopoulos A, Tangoulis V, Psycharis V, Raptopoulou C, Kessissoglou D . Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes. Dalton Trans. 2010; 39(19):4517-28. DOI: 10.1039/b927472c. View

15.

Lison D, van den Brule S, Van Maele-Fabry G . Cobalt and its compounds: update on genotoxic and carcinogenic activities. Crit Rev Toxicol. 2018; 48(7):522-539. DOI: 10.1080/10408444.2018.1491023. View

16.

Iakovidis I, Delimaris I, Piperakis S . Copper and its complexes in medicine: a biochemical approach. Mol Biol Int. 2011; 2011:594529. PMC: 3195324. DOI: 10.4061/2011/594529. View

17.

Brewer G . Copper in medicine. Curr Opin Chem Biol. 2003; 7(2):207-12. DOI: 10.1016/s1367-5931(03)00018-8. View

18.

Marzano C, Pellei M, Tisato F, Santini C . Copper complexes as anticancer agents. Anticancer Agents Med Chem. 2009; 9(2):185-211. DOI: 10.2174/187152009787313837. View

19.

Haase H, Rink L . Multiple impacts of zinc on immune function. Metallomics. 2014; 6(7):1175-80. DOI: 10.1039/c3mt00353a. View

20.

Kolenko V, Teper E, Kutikov A, Uzzo R . Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol. 2013; 10(4):219-26. PMC: 3702371. DOI: 10.1038/nrurol.2013.43. View

21.

Porchia M, Pellei M, Del Bello F, Santini C . Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents. Molecules. 2020; 25(24). PMC: 7763991. DOI: 10.3390/molecules25245814. View